Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2016 - USD ($)
Total
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid In Capital [Member]
Stockholder Note Receivable [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2015 $ 6,086,766 $ 76,573 $ 0 $ 71,209,530 $ (58,824) $ 114,788 $ (65,255,301)
Balance (in shares) at Dec. 31, 2015   7,657,287 0        
Stock-based compensation 113,360     113,360      
Shares issued and issuable to Jade Therapeutics, Inc. stockholders at acquisition 2,909,766 $ 6,891 $ 291,536 2,611,339      
Shares issued and issuable to Jade Therapeutics, Inc. stockholders at acquisition (in shares)   689,157 76,571        
Foreign currency translation adjustment (563)         (563)  
Net loss (2,442,433)           (2,442,433)
Balance at Mar. 31, 2016 $ 6,666,896 $ 83,464 $ 291,536 $ 73,934,229 $ (58,824) $ 114,225 $ (67,697,734)
Balance (in shares) at Mar. 31, 2016   8,346,444 76,571